Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0142 USD | -4.70% | +0.71% | -77.81% |
Financials (USD)
Sales 2022 | 16.84 | Sales 2023 | 18.22 | Capitalization | 1.28M |
---|---|---|---|---|---|
Net income 2022 | -76M | Net income 2023 | 53M | EV / Sales 2022 | 4,528,434 x |
Net Debt 2022 | 68.36M | Net Debt 2023 | 43.37M | EV / Sales 2023 | 2,451,077 x |
P/E ratio 2022 |
-0.05
x | P/E ratio 2023 |
1.2
x | Employees | 38 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
Latest transcript on Evofem Biosciences, Inc.
1 day | -4.70% | ||
1 week | +0.71% | ||
Current month | -41.08% | ||
1 month | -26.04% | ||
3 months | -49.29% | ||
6 months | -82.47% | ||
Current year | -77.81% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 12-12-31 | |
Ivy Zhang
DFI | Director of Finance/CFO | 46 | 18-02-28 |
Amy Raskopf
IRC | Investor Relations Contact | - | 18-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 12-12-31 | |
Kim Kamdar
BRD | Director/Board Member | 56 | 17-12-31 |
Colin Rutherford
BRD | Director/Board Member | 65 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.0142 | -4.70% | 178,028 |
24-04-24 | 0.0149 | +16.04% | 740,620 |
24-04-23 | 0.0128 | -19.25% | 1,921,977 |
24-04-22 | 0.0159 | +3.25% | 157,974 |
24-04-19 | 0.0154 | +9.22% | 369,086 |
Delayed Quote OTC Markets, April 25, 2024 at 03:55 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-77.81% | 766K | |
+24.17% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.45% | 233B | |
+6.04% | 201B | |
-10.51% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- EVFM Stock